132 related articles for article (PubMed ID: 19188762)
1. Successful use of darunavir, etravirine, enfuvirtide and tenofovir/emtricitabine in pregnant woman with multiclass HIV resistance.
Furco A; Gosrani B; Nicholas S; Williams A; Braithwaite W; Pozniak A; Taylor G; Asboe D; Lyall H; Shaw A; Kapembwa M
AIDS; 2009 Jan; 23(3):434-5. PubMed ID: 19188762
[No Abstract] [Full Text] [Related]
2. [German-Austrian guidelines for HIV therapy during pregnancy (May, 2001, update].
Buchholz B; ;
Dtsch Med Wochenschr; 2003 May; 128 Suppl 1():S19-31. PubMed ID: 12736864
[No Abstract] [Full Text] [Related]
3. Decreased plasma levels of darunavir/ritonavir in a vertically infected pregnant woman carrying multiclass-resistant HIV type-1.
Pinnetti C; Tamburrini E; Ragazzoni E; De Luca A; Navarra P
Antivir Ther; 2010; 15(1):127-9. PubMed ID: 20167999
[TBL] [Abstract][Full Text] [Related]
4. Successful prevention of HIV mother-to-child transmission with dolutegravir-based combination antiretroviral therapy in a vertically infected pregnant woman with multiclass highly drug-resistant HIV-1.
Pinnetti C; Tintoni M; Ammassari A; Tamburrini E; Bernardi S; Liuzzi G; Scambia G; Perno CF; Floridia M; Antinori A; Cavaliere AF
AIDS; 2015 Nov; 29(18):2534-7. PubMed ID: 26372490
[No Abstract] [Full Text] [Related]
5. Treatment. Study findings show HAART drugs benefit pregnant women.
AIDS Policy Law; 2007 Oct; 22(19):2. PubMed ID: 18210649
[No Abstract] [Full Text] [Related]
6. Treatment. Study could revolutionize HIV policies for pregnant women.
AIDS Policy Law; 2007 Oct; 22(19):2. PubMed ID: 18203398
[No Abstract] [Full Text] [Related]
7. Good news for women living with HIV.
Anastos K
J Infect Dis; 2007 Oct; 196(7):971-3. PubMed ID: 17763315
[No Abstract] [Full Text] [Related]
8. Tolerance and viral resistance after single-dose nevirapine with tenofovir and emtricitabine to prevent vertical transmission of HIV-1.
; Arrivé E; Chaix ML; Nerrienet E; Blanche S; Rouzioux C; Coffie PA; Kruy Leang S; McIntyre J; Avit D; Srey VH; Gray G; N'Dri-Yoman T; Diallo A; Ekouévi DK; Dabis F
AIDS; 2009 Apr; 23(7):825-33. PubMed ID: 19307941
[TBL] [Abstract][Full Text] [Related]
9. Twins with cardiomyopathy and complete heart block born to an HIV-infected mother treated with HAART.
Lopriore E; Rozendaal L; Gelinck LB; Bökenkamp R; Boelen CC; Walther FJ
AIDS; 2007 Nov; 21(18):2564-5. PubMed ID: 18025905
[No Abstract] [Full Text] [Related]
10. [Treatment of HIV-infected pregnant women: prevention of virus transmission and adverse effects in mother and child].
Boer K; Nellen JF; Kreyenbroek ME; Godfried MH
Ned Tijdschr Geneeskd; 2009; 153():B410. PubMed ID: 19785876
[TBL] [Abstract][Full Text] [Related]
11. Raltegravir: new Drug. Alternative to enfuvirtide/darunavir in multidrug-resistant HIV.
Prescrire Int; 2008 Aug; 17(96):135-7. PubMed ID: 19480091
[TBL] [Abstract][Full Text] [Related]
12. Influence of highly active antiretroviral treatment (HAART) on risk factors for vertical HIV transmission.
Garcia-Tejedor A; Maiques V; Perales A; Lopez-Aldeguer J
Acta Obstet Gynecol Scand; 2009; 88(8):882-7. PubMed ID: 19557554
[TBL] [Abstract][Full Text] [Related]
13. Prevention of mother-to-child transmission of multi-drug resistant HIV-1 using maternal therapy with both enfuvirtide and tipranavir.
Wensing AM; Boucher CA; van Kasteren M; van Dijken PJ; Geelen SP; Juttmann JR
AIDS; 2006 Jun; 20(10):1465-7. PubMed ID: 16791028
[No Abstract] [Full Text] [Related]
14. Resistance to antiretrovirals in HIV-infected pregnant women.
Weinberg A; Forster-Harwood J; McFarland EJ; Pappas J; Davies JK; Kinzie K; Barr EA; Paul SM; Salbenblatt CR; Soda E; Vazquez A; Levin MJ
J Clin Virol; 2009 May; 45(1):39-42. PubMed ID: 19329355
[TBL] [Abstract][Full Text] [Related]
15. Is the time for an AIDS-free new generation different in resource-limited and industrialized countries?
Russo G; Lichtner M; Traditi F; Vullo V
AIDS; 2009 Jan; 23(3):293-6. PubMed ID: 19114853
[No Abstract] [Full Text] [Related]
16. British HIV Association and Children's HIV Association guidelines for the management of HIV infection in pregnant women 2008.
de Ruiter A; Mercey D; Anderson J; Chakraborty R; Clayden P; Foster G; Gilling-Smith C; Hawkins D; Low-Beer N; Lyall H; O'Shea S; Penn Z; Short J; Smith R; Sonecha S; Tookey P; Wood C; Taylor G
HIV Med; 2008 Aug; 9(7):452-502. PubMed ID: 18840151
[No Abstract] [Full Text] [Related]
17. Prevention of human immunodeficiency virus mother-to-child transmission in Israel.
Agmon-Levin N; Elbirt D; Asher I; Torten D; Cohen Y; Gradestein S; Werner B; Turner D; Chowers M; Gottesman G; Maayan S; Risenberg K; Levi I; Sthoeger Z
Int J STD AIDS; 2009 Jul; 20(7):473-6. PubMed ID: 19541889
[TBL] [Abstract][Full Text] [Related]
18. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
Panel de expertos de Gesida y Plan Nacional sobre el Sida
Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
[TBL] [Abstract][Full Text] [Related]
19. [Cross-sectional study on rates and influential factors of standard medication for antiretroviral therapy in preventing mother-to-child transmission of HIV].
Wang YZ; Li Y; Jiang CQ; Zheng M; Zhang Y; Xiong YH; Yang YY; Luo KM
Zhonghua Yu Fang Yi Xue Za Zhi; 2009 Apr; 43(4):277-81. PubMed ID: 19534946
[TBL] [Abstract][Full Text] [Related]
20. FDA notifications. Revised guidelines for pregnant women.
AIDS Alert; 2007 Dec; 22(12):141. PubMed ID: 18411483
[No Abstract] [Full Text] [Related]
[Next] [New Search]
